- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in serum institute of india
Serum Institute Doubles Its Investment In Biocon Biologics To 300 Mn
Biocon Biologics (BBL) on Tuesday said that the company and Serum Institute of Life Sciences (SILS) have reached an agreement to withdraw from the original equity structure contemplated under their Strategic Alliance announced in September 2021
Read More
Serum Institute In Talks On Fill-Finishing Malaria Vaccine In Ghana, Official Says
Fill-finishing is one of the final stages of drug manufacturing and packaging. The vaccine's approval by Ghana and Nigeria was unusual because final-stage trial data has not yet been published and the World Health Organisation (WHO) is still assessing its safety and effectiveness.
Read More
Serum Institute Restarts Covishield Manufacturing: Adar Poonawalla
The company has availability of six million booster doses and adults must take the booster shot, he added
Read More
SII To Make Ebola Vaccine For Uganda Outbreak
The response to Uganda's outbreak has been blunted by the absence of a proven vaccine against the Sudan strain of the virus. There have been 54 confirmed cases and 19 deaths since last month and the first case in the capital, Kampala, was recorded last week
Read More
Global Certification Of Vaccines An Imperative, Need Intervention From UN, WTO: Poonawalla
Serum Institute of India Chief Executive Officer Adar Poonawalla asked the multilateral organisations like the UN and the WTO to take it upon themselves to harmonise the certification of vaccines ahead of another pandemic
Read More
SII To Govt: Can Supply 1 Cr Doses of qHPV Vaccine Against Cervical Cancer
The phase 2/3 clinical trial of the vaccine has been completed with the support of the Department of Biotechnology. The government advisory panel NTAGI recently is learnt to have also approved the qHPV after reviewing the clinical trial data of the vaccine
Read More
SII In Talks With Bavarian Nordic For Importing Monkeypox Caccine
With only a handful cases of monkeypox in the country at the moment, he said for initiating local development of the vaccine SII would have to wait and watch for a few months to assess the real demand scenario. India has reported four cases monkeypox, including three in Kerala, so far
Read More
SII To Announce Indigenous Vaccine To Treat Cervical Cancer
The company had applied to the DCGI seeking market authorisation of the qHPV after the phase 2/3 clinical trial was completed with support of the Department of Biotechnology. Cervical cancer in India ranks as the second most frequent cancer among women between 15 and 44 years of age
Read More
SII Seeks Clearance To Export Covid Vaccine Covovax To US
According to a communication sent to the government by Prakash Kumar Singh, Director, Government and Regulatory Affairs at the SII, the shipment is likely to be dispatched on July 3 if due approval come in time, an official source told PTI. The sources said it will be the first instance of any Indian manufacturer's vaccine Covid or non-Covid to be exported to the US
Read More
SII's Covovax Gets DCGI's Nod For Emergency Use In Children Aged 7-11 Yrs
The drug regulator has also approved Serum Institute's COVID-19 vaccine Covovax for restricted emergency use in children aged 7 to 11 years subject to certain conditions
Read More
Indian Vaccine Manufacturer SII Plans African Plant
Africa was the only continent that did not have its own manufacturing capacity for COVID shots during the worst phases of the pandemic in the last two years, leaving it at the mercy of suppliers from overseas, including the SII
Read More
CCI Approves Serum Institute Life Sciences-Biocon Biologics Deal
Once the deal is complete, Serum Institute Life Sciences Pvt Ltd will have about 15 per cent stake in Biocon Biologics Ltd, according to the notice filed with the regulator
Read More
Serum's Covavax Vaccine Now Available For 12-17 Age Group At Pvt Hospitals: Report
Serum Institute of India (SII) Director for Government and Regulatory Affairs Prakash Kumar Singh had written to the Union Health Ministry recently, requesting for Covovax's inclusion in the immunisation drive for children aged 12 to 17 years
Read More
Covishield And Covaxin Doses To Cost Rs 225 Now In Private Hospitals
The Serum Institute of India has cut the rates of Covishield from ₹600 to ₹225 per dose, while Bharat Biotech has brought down the price of Covaxin from ₹1,200 to ₹225
Read More
India Has No Plans For Vaccine Booster: Sources
As vaccine supplies have increased, some doctors and public health experts in India have urged the government to start a booster programme for the most vulnerable like many Western nations have done.
Read More